Journey Medical (DERM) Total Debt (2020 - 2026)

Journey Medical's Total Debt history runs 7 years deep, the most recent figure standing at $25.4 million for Q1 2026.

• Quarterly Total Debt rose 1.57% year-over-year to $25.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.4 million (up 1.57% YoY) and the FY2025 annual result came in at $25.3 million, up 1.6% from the prior year.
• Total Debt was $25.4 million for Q1 2026 at Journey Medical, roughly flat from $25.3 million in the prior quarter.
• Across five years, Total Debt topped out at $32.8 million in Q1 2023 and bottomed at $14.6 million in Q4 2023.
• A 5-year average of $21.5 million and a median of $21.3 million in 2022 frame the typical range for Total Debt.
• Annual changes were most pronounced in 2022 — Total Debt soared 1302.34% — and 2024, when it tumbled 55.17%.
• Journey Medical's Total Debt stood at $22.8 million in 2022, then plunged by 35.8% to $14.6 million in 2023, then surged by 70.15% to $24.9 million in 2024, then advanced by 1.6% to $25.3 million in 2025, then grew by 0.38% to $25.4 million in 2026.
• Business Quant data shows DERM's Total Debt at $25.4 million in Q1 2026, $25.3 million in Q4 2025, and $25.2 million in Q3 2025.